Skip to main content
logo
TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
59.83
+1.85 (3.18%)
At close: Nov 6, 2026, 4:00 PM EST
59.75
-0.08 (-0.13%)
After-hours: Nov 6, 2026, 7:45 PM EST

TG Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Revenue
240.34204.92192.57161.71141.15120.86108.1983.8873.4763.4743.97165.8216.077.80.080.090.592.022.322.03
Revenue Growth
70.27%69.56%78.00%92.79%92.13%90.40%146.04%-49.41%357.05%713.46%54863.75%176298.94%2606.06%287.05%-96.55%-95.37%-61.55%154.22%6007.89%5242.11%
Gross Profit
199.14171.41154.43133.62122.21105.3292.7974.5465.1658.0336.12162.3114.166.950.080.090.571.782.111.74
Operating Income
21.6734.850.4929.3734.848.6229.9512.438.82-9.27-12.49114.78-44.67-36.99-52.06-34.96-38.94-66.87-92.95-85.13
Net Income
7.7819.7823.04390.928.195.0623.333.886.88-10.71-14.42113.93-47.61-39.23-52.99-35.82-40.51-69.01-93.34-85.64
Earnings Per Share
0.050.120.142.430.170.030.150.020.04-0.07-0.100.73-0.34-0.28-0.39-0.26-0.30-0.51-0.70-0.65
EPS Growth
-70.59%300.01%-6.13%12049.99%325.00%---97.26%------------

Revenue by Segment
Chart
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Product Revenue, Net
235.79201.31189.11159.32138.84119.66107.3583.372.650.4943.1425.0716.047.770.040.060.561.982.281.99
Total License, Milestone, Royalty and Other
4.543.613.462.392.311.20.840.580.8712.990.83140.750.040.040.040.040.040.040.040.04
Revenue (Total)
240.34204.92192.57161.71141.15120.86108.1983.8873.4763.4743.97165.8216.077.80.080.090.592.022.322.03

Cash & Debt
Chart
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Cash & Investments
552.25514.43141.97131.58251.87276.24311341.04217.25209.79217.51229.16144.91139.71161.68175.94195.71233.2314.76356.85
Total Debt
754.44753.56254.4254.54254.53254.58254.38253.81112.92111.99111.15110.08109.02108.4383.382.3680.4979.2479.4128.11
Net Cash (Debt)
-202.19-239.13-112.43-122.96-2.6621.6656.6287.23104.3397.79106.36119.0835.8931.2878.3893.59115.22153.96235.36328.74
Net Cash Growth
------77.85%-46.76%-26.74%190.72%212.65%35.70%27.24%-68.85%-79.68%-66.70%-71.53%-71.75%-67.99%-58.16%54.63%
Net Cash Per Share
-1.29-1.49-0.71-0.76-0.020.130.350.540.650.670.740.760.250.220.570.690.851.151.782.48

Cash Flow & CapEx
Chart
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Operating Cash Flow
39.26-17.8919.66-23.157.44-28.72-25.64-12.215.54-8.21-13.2183.7-42.01-59.9-23.87-34.5-49.12-68.69-86.91-67.2
Capital Expenditures
-0.29-0.05-0.07-0.08-0.04-0.03-0.02-0.02-------0-0--0.01-0.08-0.08
Free Cash Flow
38.97-17.9519.59-23.237.39-28.74-25.66-12.235.54-8.21-13.2183.7-42.01-59.9-23.87-34.5-49.12-68.7-86.99-67.28
Free Cash Flow Growth
427.05%---33.56%---------------

Margins
Chart
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Gross Margin
82.86%83.65%80.19%82.63%86.58%87.14%85.77%88.86%88.70%91.43%82.14%97.88%88.11%89.02%96.25%97.87%96.13%88.24%90.95%85.62%
Operating Margin
9.02%16.98%26.22%18.16%24.69%7.13%27.68%14.82%12.00%-14.60%-28.39%69.22%-277.93%-474.07%-65077.50%-37194.68%-6555.72%-3317.06%-4004.61%-4193.50%
Pretax Margin
4.26%9.94%23.42%16.02%21.91%4.52%23.53%5.09%8.92%-16.82%-31.90%68.71%-296.19%-502.78%-66242.50%-38104.26%-6819.87%-3423.26%-4021.46%-4218.57%
Profit Margin
3.24%9.65%11.96%241.73%19.97%4.19%21.57%4.63%9.36%-16.87%-32.78%68.71%-296.19%-502.78%-66242.50%-38104.25%-6819.86%-3423.26%-4021.46%-4218.57%
FCF Margin
16.21%-8.76%10.17%-14.37%5.24%-23.78%-23.72%-14.58%7.54%-12.93%-30.04%50.48%-261.32%-767.68%-29841.25%-36701.06%-8268.69%-3407.54%-3747.91%-3314.29%

Valuation
Chart
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
PE Ratio
17.6410.629.7511.7886.80146.27184.75-26.61-----------
Forward PE
31.3224.9720.2926.1130.9837.1045.2156.40198.33134.45134.45134.45--------
P/FCF Ratio
447.87-------37.55-----------
PS Ratio
9.747.017.079.9111.5614.8213.1312.677.357.6110.346.22143.45241.51569.04159.3681.19157.20371.96987.39